Managing plasma cell leukemia

被引：10

作者：

Gertz, Morie A. ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

来源：

LEUKEMIA & LYMPHOMA | 2007年 / 48卷 / 01期

关键词：

MULTIPLE-MYELOMA; TRANSPLANTATION; VAD;

D O I：

10.1080/10428190600972527

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5 / 6

页数：2

共 9 条

[1] Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia:: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique [J].

Avet-Loiseau, H ;

Daviet, A ;

Brigaudeau, C ;

Callet-Bauchu, E ;

Terré, C ;

Lafage-Pochitaloff, M ;

Désangles, F ;

Ramond, S ;

Talmant, P ;

Bataille, R .

BLOOD, 2001, 97 (03) :822-825

[2] Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia [J].

Bladé, J ;

Kyle, RA .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (06) :1259-+

[3] Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature [J].

Hovenga, S ;

deWolf, JTM ;

Klip, H ;

Vellenga, E .

BONE MARROW TRANSPLANTATION, 1997, 20 (10) :901-904

[4]

Kyle RA, 2003, BRIT J HAEMATOL, V121, P749

[5] The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma [J].

Pellat-Deceunynck, C ;

Barillé, S ;

Jego, G ;

Puthier, D ;

Robillard, N ;

Pineau, D ;

Rapp, MJ ;

Harousseau, JL ;

Amiot, M ;

Bataille, R .

LEUKEMIA, 1998, 12 (12) :1977-1982

[6]

PETRUCCI MT, 2006, LEUKEMIA LYMPHOMA, V18, P180

[7] Primary plasma cell leukemia: Report of 17 new cases treated with autologous or allogeneic stem-cell transplantation and review of the literature [J].

Saccaro, S ;

Fonseca, R ;

Veillon, DM ;

Cotelingam, J ;

Nordberg, ML ;

Bredeson, C ;

Glass, J ;

Munker, R .

AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (04) :288-294

[8] Diagnosis of plasma cell leukaemia: findings of the UKNEQAS for Leucocyte Immunophenotyping scheme [J].

Veen, JJ ;

Reilly, JT ;

Richards, SJ ;

Whitby, L ;

Goodfellow, K ;

Granger, V ;

Rees, DC ;

Barnett, D .

CLINICAL AND LABORATORY HAEMATOLOGY, 2004, 26 (01) :37-42

[9] Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia [J].

Vela-Ojeda, J ;

Esparza, MAGR ;

Rosas-Cabral, A ;

Padilla-González, Y ;

García-Chávez, J ;

Tripp-Villanueva, F ;

Sánchez-Cortés, E ;

Ayala-Sánchez, M ;

García-León, LD ;

Montiel-Cervantes, L ;

Rubio-Borja, ME .

ANNALS OF HEMATOLOGY, 2002, 81 (07) :362-367

← 1 →